Charles River Laboratories International, Inc.
CRL
$3.25 (1.41%)
1D
1W
3M
1Y
5Y
ALL
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 5 days ago • CRL
Charles River Prepares to Report Q2 Earnings: What's in Store?
Zacks Investment Research • 6 days ago • CRL
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Zacks Investment Research • 18 days ago • CRL
What Makes Charles River Laboratories (CRL) a Strong Momentum Stock: Buy Now?
Zacks Investment Research • 21 days ago • CRL
Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?
PRNewsWire • about a month ago • CRL
Did Charles River Laboratories International, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.